Click for best price
Peritoneal Cancer Market Size, Share 2022
Peritoneal cancer is also known as serous surface papillary carcinoma, primary peritoneal carcinoma, extra-ovarian serous carcinoma, primary serous papillary carcinoma and psammomacarcinoma.
This report contains market size and forecasts of Peritoneal Cancer in Global, including the following market information:
Global Peritoneal Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Peritoneal Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Surgery Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peritoneal Cancer include AstraZeneca, GlaxoSmithKline, Oxford BioMedica, Millennium Pharmaceuticals, Novartis, Bayer, Incyte, EntreMed and Oncolytics Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Peritoneal Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peritoneal Cancer Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Peritoneal Cancer Market Segment Percentages, by Type, 2021 (%)
Surgery
Chemotherapy (Anticancer Drugs)
Radiotherapy (High-Energy Rays)
Global Peritoneal Cancer Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Peritoneal Cancer Market Segment Percentages, by Application, 2021 (%)
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Global Peritoneal Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Peritoneal Cancer Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peritoneal Cancer revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Peritoneal Cancer revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
GlaxoSmithKline
Oxford BioMedica
Millennium Pharmaceuticals
Novartis
Bayer
Incyte
EntreMed
Oncolytics Biotech
Synta Pharmaceuticals
Oasmia Pharmaceutical
| Report Attributes |
Report Details |
| Report Title |
Peritoneal Cancer Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Peritoneal Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peritoneal Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peritoneal Cancer Overall Market Size
2.1 Global Peritoneal Cancer Market Size: 2021 VS 2028
2.2 Global Peritoneal Cancer Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peritoneal Cancer Players in Global Market
3.2 Top Global Peritoneal Cancer Companies Ranked by Revenue
3.3 Global Peritoneal Cancer Revenue by Companies
3.4 Top 3 and Top 5 Peritoneal Cancer Companies in Global Market, by Revenue in 2021
3.5 Global Companies Peritoneal Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peritoneal Cancer Players in Global Market
3.6.1 List of Global Tier 1 Peritoneal Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Peritoneal Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Peritoneal Cancer Market Size Markets, 2021 & 2028
4.1.2 Surgery
4.1.3 Chemotherapy (Anticancer Drugs)
4.1.4 Radiotherapy (High-Energy Rays)
4.2 By Type - Global Peritoneal Cancer Revenue & Forecasts
4.2.1 By Type - Global Peritoneal Cancer Revenue, 2017-2022
4.2.2 By Type - Global Peritoneal Cancer Revenue, 2023-2028
4.2.3 By Type - Global Peritoneal Cancer Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peritoneal Cancer Market Size, 2021 & 2028
5.1.2 Cancer Research Centers
5.1.3 Cancer Hospital
5.1.4 Surgical Centers
5.1.5 Clinics
5.2 By Application - Global Peritoneal Cancer Revenue & Forecasts
5.2.1 By Application - Global Peritoneal Cancer Revenue, 2017-2022
5.2.2 By Application - Global Peritoneal Cancer Revenue, 2023-2028
5.2.3 By Application - Global Peritoneal Cancer Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Peritoneal Cancer Market Size, 2021 & 2028
6.2 By Region - Global Peritoneal Cancer Revenue & Forecasts
6.2.1 By Region - Global Peritoneal Cancer Revenue, 2017-2022
6.2.2 By Region - Global Peritoneal Cancer Revenue, 2023-2028
6.2.3 By Region - Global Peritoneal Cancer Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Peritoneal Cancer Revenue, 2017-2028
6.3.2 US Peritoneal Cancer Market Size, 2017-2028
6.3.3 Canada Peritoneal Cancer Market Size, 2017-2028
6.3.4 Mexico Peritoneal Cancer Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Peritoneal Cancer Revenue, 2017-2028
6.4.2 Germany Peritoneal Cancer Market Size, 2017-2028
6.4.3 France Peritoneal Cancer Market Size, 2017-2028
6.4.4 U.K. Peritoneal Cancer Market Size, 2017-2028
6.4.5 Italy Peritoneal Cancer Market Size, 2017-2028
6.4.6 Russia Peritoneal Cancer Market Size, 2017-2028
6.4.7 Nordic Countries Peritoneal Cancer Market Size, 2017-2028
6.4.8 Benelux Peritoneal Cancer Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Peritoneal Cancer Revenue, 2017-2028
6.5.2 China Peritoneal Cancer Market Size, 2017-2028
6.5.3 Japan Peritoneal Cancer Market Size, 2017-2028
6.5.4 South Korea Peritoneal Cancer Market Size, 2017-2028
6.5.5 Southeast Asia Peritoneal Cancer Market Size, 2017-2028
6.5.6 India Peritoneal Cancer Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Peritoneal Cancer Revenue, 2017-2028
6.6.2 Brazil Peritoneal Cancer Market Size, 2017-2028
6.6.3 Argentina Peritoneal Cancer Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Peritoneal Cancer Revenue, 2017-2028
6.7.2 Turkey Peritoneal Cancer Market Size, 2017-2028
6.7.3 Israel Peritoneal Cancer Market Size, 2017-2028
6.7.4 Saudi Arabia Peritoneal Cancer Market Size, 2017-2028
6.7.5 UAE Peritoneal Cancer Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Peritoneal Cancer Major Product Offerings
7.1.4 AstraZeneca Peritoneal Cancer Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca Key News
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporate Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Peritoneal Cancer Major Product Offerings
7.2.4 GlaxoSmithKline Peritoneal Cancer Revenue in Global Market (2017-2022)
7.2.5 GlaxoSmithKline Key News
7.3 Oxford BioMedica
7.3.1 Oxford BioMedica Corporate Summary
7.3.2 Oxford BioMedica Business Overview
7.3.3 Oxford BioMedica Peritoneal Cancer Major Product Offerings
7.3.4 Oxford BioMedica Peritoneal Cancer Revenue in Global Market (2017-2022)
7.3.5 Oxford BioMedica Key News
7.4 Millennium Pharmaceuticals
7.4.1 Millennium Pharmaceuticals Corporate Summary
7.4.2 Millennium Pharmaceuticals Business Overview
7.4.3 Millennium Pharmaceuticals Peritoneal Cancer Major Product Offerings
7.4.4 Millennium Pharmaceuticals Peritoneal Cancer Revenue in Global Market (2017-2022)
7.4.5 Millennium Pharmaceuticals Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Peritoneal Cancer Major Product Offerings
7.5.4 Novartis Peritoneal Cancer Revenue in Global Market (2017-2022)
7.5.5 Novartis Key News
7.6 Bayer
7.6.1 Bayer Corporate Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Peritoneal Cancer Major Product Offerings
7.6.4 Bayer Peritoneal Cancer Revenue in Global Market (2017-2022)
7.6.5 Bayer Key News
7.7 Incyte
7.7.1 Incyte Corporate Summary
7.7.2 Incyte Business Overview
7.7.3 Incyte Peritoneal Cancer Major Product Offerings
7.7.4 Incyte Peritoneal Cancer Revenue in Global Market (2017-2022)
7.7.5 Incyte Key News
7.8 EntreMed
7.8.1 EntreMed Corporate Summary
7.8.2 EntreMed Business Overview
7.8.3 EntreMed Peritoneal Cancer Major Product Offerings
7.8.4 EntreMed Peritoneal Cancer Revenue in Global Market (2017-2022)
7.8.5 EntreMed Key News
7.9 Oncolytics Biotech
7.9.1 Oncolytics Biotech Corporate Summary
7.9.2 Oncolytics Biotech Business Overview
7.9.3 Oncolytics Biotech Peritoneal Cancer Major Product Offerings
7.9.4 Oncolytics Biotech Peritoneal Cancer Revenue in Global Market (2017-2022)
7.9.5 Oncolytics Biotech Key News
7.10 Synta Pharmaceuticals
7.10.1 Synta Pharmaceuticals Corporate Summary
7.10.2 Synta Pharmaceuticals Business Overview
7.10.3 Synta Pharmaceuticals Peritoneal Cancer Major Product Offerings
7.10.4 Synta Pharmaceuticals Peritoneal Cancer Revenue in Global Market (2017-2022)
7.10.5 Synta Pharmaceuticals Key News
7.11 Oasmia Pharmaceutical
7.11.1 Oasmia Pharmaceutical Corporate Summary
7.11.2 Oasmia Pharmaceutical Business Overview
7.11.3 Oasmia Pharmaceutical Peritoneal Cancer Major Product Offerings
7.11.4 Oasmia Pharmaceutical Peritoneal Cancer Revenue in Global Market (2017-2022)
7.11.5 Oasmia Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Peritoneal Cancer Market Opportunities & Trends in Global Market
Table 2. Peritoneal Cancer Market Drivers in Global Market
Table 3. Peritoneal Cancer Market Restraints in Global Market
Table 4. Key Players of Peritoneal Cancer in Global Market
Table 5. Top Peritoneal Cancer Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Peritoneal Cancer Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Peritoneal Cancer Revenue Share by Companies, 2017-2022
Table 8. Global Companies Peritoneal Cancer Product Type
Table 9. List of Global Tier 1 Peritoneal Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peritoneal Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Peritoneal Cancer Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Peritoneal Cancer Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Peritoneal Cancer Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Peritoneal Cancer Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Peritoneal Cancer Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Peritoneal Cancer Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Peritoneal Cancer Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Peritoneal Cancer Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Peritoneal Cancer Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Peritoneal Cancer Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Peritoneal Cancer Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Peritoneal Cancer Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Peritoneal Cancer Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Peritoneal Cancer Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Peritoneal Cancer Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Peritoneal Cancer Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Peritoneal Cancer Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Peritoneal Cancer Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Peritoneal Cancer Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Peritoneal Cancer Product Offerings
Table 32. AstraZeneca Peritoneal Cancer Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline Corporate Summary
Table 34. GlaxoSmithKline Peritoneal Cancer Product Offerings
Table 35. GlaxoSmithKline Peritoneal Cancer Revenue (US$, Mn), (2017-2022)
Table 36. Oxford BioMedica Corporate Summary
Table 37. Oxford BioMedica Peritoneal Cancer Product Offerings
Table 38. Oxford BioMedica Peritoneal Cancer Revenue (US$, Mn), (2017-2022)
Table 39. Millennium Pharmaceuticals Corporate Summary
Table 40. Millennium Pharmaceuticals Peritoneal Cancer Product Offerings
Table 41. Millennium Pharmaceuticals Peritoneal Cancer Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Peritoneal Cancer Product Offerings
Table 44. Novartis Peritoneal Cancer Revenue (US$, Mn), (2017-2022)
Table 45. Bayer Corporate Summary
Table 46. Bayer Peritoneal Cancer Product Offerings
Table 47. Bayer Peritoneal Cancer Revenue (US$, Mn), (2017-2022)
Table 48. Incyte Corporate Summary
Table 49. Incyte Peritoneal Cancer Product Offerings
Table 50. Incyte Peritoneal Cancer Revenue (US$, Mn), (2017-2022)
Table 51. EntreMed Corporate Summary
Table 52. EntreMed Peritoneal Cancer Product Offerings
Table 53. EntreMed Peritoneal Cancer Revenue (US$, Mn), (2017-2022)
Table 54. Oncolytics Biotech Corporate Summary
Table 55. Oncolytics Biotech Peritoneal Cancer Product Offerings
Table 56. Oncolytics Biotech Peritoneal Cancer Revenue (US$, Mn), (2017-2022)
Table 57. Synta Pharmaceuticals Corporate Summary
Table 58. Synta Pharmaceuticals Peritoneal Cancer Product Offerings
Table 59. Synta Pharmaceuticals Peritoneal Cancer Revenue (US$, Mn), (2017-2022)
Table 60. Oasmia Pharmaceutical Corporate Summary
Table 61. Oasmia Pharmaceutical Peritoneal Cancer Product Offerings
Table 62. Oasmia Pharmaceutical Peritoneal Cancer Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Peritoneal Cancer Segment by Type in 2021
Figure 2. Peritoneal Cancer Segment by Application in 2021
Figure 3. Global Peritoneal Cancer Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Peritoneal Cancer Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Peritoneal Cancer Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Peritoneal Cancer Revenue in 2021
Figure 8. By Type - Global Peritoneal Cancer Revenue Market Share, 2017-2028
Figure 9. By Application - Global Peritoneal Cancer Revenue Market Share, 2017-2028
Figure 10. By Region - Global Peritoneal Cancer Revenue Market Share, 2017-2028
Figure 11. By Country - North America Peritoneal Cancer Revenue Market Share, 2017-2028
Figure 12. US Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Peritoneal Cancer Revenue Market Share, 2017-2028
Figure 16. Germany Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 17. France Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Peritoneal Cancer Revenue Market Share, 2017-2028
Figure 24. China Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 28. India Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Peritoneal Cancer Revenue Market Share, 2017-2028
Figure 30. Brazil Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Peritoneal Cancer Revenue Market Share, 2017-2028
Figure 33. Turkey Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Peritoneal Cancer Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Peritoneal Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline Peritoneal Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Oxford BioMedica Peritoneal Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Millennium Pharmaceuticals Peritoneal Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Peritoneal Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bayer Peritoneal Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Incyte Peritoneal Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. EntreMed Peritoneal Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Oncolytics Biotech Peritoneal Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Synta Pharmaceuticals Peritoneal Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Oasmia Pharmaceutical Peritoneal Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
